These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30822244)

  • 21. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.
    Balbi B; Sangiorgi C; Gnemmi I; Ferrarotti I; Vallese D; Paracchini E; Delle Donne L; Corda L; Baderna P; Corsico A; Carone M; Brun P; Cappello F; Ricciardolo FL; Ruggeri P; Mumby S; Adcock IM; Caramori G; Di Stefano A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1879-1893. PubMed ID: 31686800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trace elements and oxidative stress in chronic obstructive pulmonary disease.
    Isik B; Isik RS; Ceylan A; Calik O
    Saudi Med J; 2005 Dec; 26(12):1882-5. PubMed ID: 16380766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
    Carleo A; Chorostowska-Wynimko J; Koeck T; Mischak H; Czajkowska-Malinowska M; Rozy A; Welte T; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():829-837. PubMed ID: 28331304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of alpha-1 antitrypsin deficiency.
    Ranes J; Stoller JK
    Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Obstructive Pulmonary Disease. A Biomarker and a Potential Therapy.
    Turino GM
    Ann Am Thorac Soc; 2018 Feb; 15(Suppl 1):S15-S17. PubMed ID: 29461896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild-moderate ex-smoker COPD patients with persistent oxidative stress.
    Fratta Pasini AM; Ferrari M; Stranieri C; Vallerio P; Mozzini C; Garbin U; Zambon G; Cominacini L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1733-43. PubMed ID: 27555763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.
    Greulich T; Vogelmeier CF
    Ther Adv Respir Dis; 2016 Feb; 10(1):72-84. PubMed ID: 26341117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of HIV infection on α
    Stephenson SE; Wilson CL; Crothers K; Attia EF; Wongtrakool C; Petrache I; Schnapp LM
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L583-L592. PubMed ID: 29351445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarities in the Computed Tomography Appearance in α1-Antitrypsin Deficiency and Smoking-Related Chronic Obstructive Pulmonary Disease in a Smoking Collective.
    Konietzke P; Jobst B; Wagner WL; Jarosch I; Graber R; Kenn K; Kauczor HU; Wielpütz MO
    Respiration; 2018; 96(3):231-239. PubMed ID: 29940576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Small Airways in Patients with Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency.
    Ferrari da Cruz T; Rufino R; Lopes AJ; Noronha A; Medeiros Anselmo F; Henrique da Costa C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2267-2274. PubMed ID: 33061344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-1 antitrypsin deficiency: From the lung to the heart?
    Curjuric I; Imboden M; Bettschart R; Caviezel S; Dratva J; Pons M; Rothe T; Schmidt-Trucksäss A; Stolz D; Thun GA; von Eckardstein A; Kronenberg F; Ferrarotti I; Probst-Hensch NM
    Atherosclerosis; 2018 Mar; 270():166-172. PubMed ID: 29432934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of emphysema distribution in smokers and patients with alpha1-antitrypsin deficiency.
    Stavngaard T; Shaker SB; Dirksen A
    Respir Med; 2006 Jan; 100(1):94-100. PubMed ID: 15882941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
    Caram LMO; Ferrari R; Nogueira DL; Oliveira M; Francisqueti FV; Tanni SE; Corrêa CR; Godoy I
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2015-2021. PubMed ID: 28744116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Alpha-1 Antitrypsin Levels and the Clinical Course of Chronic Obstructive Pulmonary Disease.
    Takei N; Suzuki M; Makita H; Konno S; Shimizu K; Kimura H; Kimura H; Nishimura M
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2885-2893. PubMed ID: 31849461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
    Liu H; Xu JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.